NASDAQ : CRON

Cronos Group Inc.

$2.79 USD

$0.04 (1.45%)

Volume
742.78K
Average Volume
1.51M
Market Capitalization
$1.04B
P/E Ratio
-1270.69
Dividend Yield
0.00%
Price Target
$2.90
Year High
$3.43
Year Low
$1.93
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$21.87
Source Headline
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

globenewswire.com - 2026-07-16 07:30:00

3 Canadian Marijuana Stocks For Better Investing And Trading 2026

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.

marijuanastocks.com - 2026-07-15 11:21:32

Top Canadian Marijuana Stock Picks For Investors Today

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

marijuanastocks.com - 2026-07-06 12:42:01

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.

globenewswire.com - 2026-06-30 17:15:00

CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

zacks.com - 2026-06-24 09:25:32

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.

globenewswire.com - 2026-06-22 17:30:00

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding.

globenewswire.com - 2026-06-22 17:30:00

3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year

A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.

marijuanastocks.com - 2026-06-17 13:26:45

Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company,  announced today that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, the Company's notice of intention to make a normal course issuer bid (the “TSX NCIB”).

globenewswire.com - 2026-06-16 16:15:00

Spinach® is the Number One Vape Brand in Canada

Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult consumers across Canada Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult consumers across Canada

globenewswire.com - 2026-06-11 07:30:00

3 Canadian Marijuana Stocks That Could Help You Make Money

Those who have been investing in marijuana stocks over the years have seen many changes. If you have been investing and trading since just before the pandemic, then you know how exciting the sector can be. With all the changes in the cannabis industry, from regulations to federal legislation, hopes are high for investors. At the start, some were filled with doubt about legal cannabis, let alone investing in marijuana stocks.

marijuanastocks.com - 2026-06-03 11:35:17

Top Canadian Marijuana Stock Choices For Better Investing In 2026

Many marijuana stock investors have a strong positive outlook on the future of the market. If you've been watching the cannabis sector, then you know how volatile and uncertain trading can be. Yet there have been changes that give more upside to what the future of investing can hold. As cannabis is now a class 3 substance federally, more companies are making shifts in their business to get in line with this new legislation.

marijuanastocks.com - 2026-05-22 10:53:02

Cronos: Strong Q1 Earnings Driven By International Cannabis Sales

Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in the Netherlands which will increase its international operations and revenue potential.

seekingalpha.com - 2026-05-14 22:03:00

Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)

Cronos Group Inc. reported Q1 '26 revenue up 40% to $45 million, exceeding estimates. Despite strong top-line growth, CRON posted a small operating loss of $1.8 million, with net income driven by interest and FX gains. CapEx dropped sharply by 87% year-over-year to $1.9 million, reflecting tighter capital discipline.

seekingalpha.com - 2026-05-13 11:39:30

Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript

Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-11 20:50:42

Cronos Group Q1 Earnings Call Highlights

Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter.

marketbeat.com - 2026-05-11 10:09:14

Cronos Group (CRON) Q1 Earnings Meet Estimates

Cronos Group (CRON) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago.

zacks.com - 2026-05-11 09:45:32

Cronos Group Reports 2026 First Quarter Results

Net revenue in Q1 2026 increased by  40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS ® continues to be the number one cannabis brand 2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2026 first quarter business results. “Cronos delivered record net revenue and gross profit in the first quarter, as we continue to execute against our borderless products strategy and as additional supply from the expansion at Cronos GrowCo fuels our next phase of growth.

globenewswire.com - 2026-05-11 07:30:00

Cronos Group Reports 2026 First Quarter Results

Net revenue in Q1 2026 increased by 40% year-over-year to $45. 2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS continues to be the number one cannabis brand2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc.

globenewswire.com - 2026-05-11 07:30:00

Cronos Expands Pre-Roll Portfolio with Spinach STIX®

TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation in its popular line-up of Spinach® pre-rolls, is now available in more provinces across Canada. Spinach STIX® is the brand's first cylindrical-style pre-roll, designed to meet surging consumer interest in this highly sought-after format in the pre-roll category1.

globenewswire.com - 2026-05-06 07:30:00

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders

TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 18, 2026, at 11:00 a.m. ET.

globenewswire.com - 2026-04-29 07:30:00

Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. Cronos Group (NASDAQ:CRON) Financial Comparison

Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and Cronos Group (NASDAQ: CRON - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation. Institutional and Insider Ownership 36.8% of Aurinia Pharmaceuticals

defenseworld.net - 2026-04-27 01:12:48

Incannex Healthcare (NASDAQ:IXHL) and Cronos Group (NASDAQ:CRON) Financial Contrast

Cronos Group (NASDAQ: CRON - Get Free Report) and Incannex Healthcare (NASDAQ: IXHL - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Analyst Recommendations This is a summary of

defenseworld.net - 2026-04-25 02:30:53

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

globenewswire.com - 2026-04-20 07:30:00

Get CRON Insider Trade Alerts

CRON Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$2.30

1 analysts

All Time

$3.15

4 analysts

CRON Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-05-15 CIBC Maintain Outperform Outperform
2024-04-08 B of A Securities Maintain Underperform Underperform
2023-12-28 B of A Securities Maintain Underperform Underperform
2023-05-15 Barclays Maintain Equal Weight Equal Weight
2022-11-02 Bernstein Maintain Market Perform Perform
2022-09-30 Barclays Maintain Equal Weight Equal Weight
2022-03-22 Barclays Upgrade Underweight Equal Weight
2022-03-07 Piper Sandler Maintain Neutral Neutral
2022-02-22 Canaccord Genuity Maintain Sell Sell
2022-02-22 Piper Sandler Maintain Neutral Neutral
2022-01-27 Jefferies Upgrade Underperform Hold
2021-11-18 Barclays Maintain Underweight Underweight
2020-04-14 Piper Sandler Downgrade Overweight Neutral
2020-03-31 Canaccord Genuity Downgrade Hold Sell
2019-11-13 Bank of America Maintain Buy Buy
2019-11-13 B of A Securities Maintain Buy Buy
2019-10-22 Piper Jaffray Maintain Overweight Overweight
2019-10-22 Piper Sandler Maintain Overweight Overweight
2019-08-13 Piper Jaffray Maintain Overweight Overweight
2019-08-09 Canaccord Genuity Upgrade Sell Hold
2019-06-28 Consumer Edge Maintain Equal Weight Equal Weight
2019-06-06 Stifel Nicolaus Maintain Hold Hold
2019-06-05 B of A Securities Upgrade Underperform Buy
2019-06-05 Bank of America Upgrade Underperform Buy
2019-04-17 Bank of America Maintain Underperform Underperform
2019-03-27 Canaccord Genuity Downgrade Hold Sell
2019-03-26 PI Financial Downgrade Buy Neutral
2019-03-11 BMO Capital Downgrade Market Perform Underperform
2019-03-05 Cowen & Co. Maintain Market Perform Perform
2019-02-25 Jefferies Maintain Underperform Underperform
2019-02-05 GMP Securities Downgrade Buy Hold
2019-01-18 CIBC Maintain Outperform Outperform
2018-08-15 Canaccord Genuity Upgrade Sell Hold